International Clinical Trial: Sotoclaro combined with R-CHOP regimen for the treatment of newly diagnosed aggressive B-cell lymphoma with BCL2 positivity: A multicenter, single-arm, open-label Ib/II phase clinical study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131616) titled 'Sotoclaro combined with R-CHOP regimen for the treatment of newly diagnosed aggressive B-cell lymphoma with BCL2 positivity: A multicenter, single-arm, open-label Ib/II phase clinical study' on Sept. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhujiang Hospital of Southern Medical University

Condition: Invasive B-cell lymphoma

Recruitment Status: Not Recruiting

Phase: 1-2

Date of First Enrollment: 2026-09-06

Target Sample Size: Experimental group:43;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=339534

Published ...